(SLAB) Silicon Laboratories - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8269191024

SLAB: Wireless Microcontrollers, Sensors, Smart Home Devices

Silicon Laboratories Inc. (NASDAQ:SLAB), a leading fabless semiconductor company, specializes in designing and delivering high-performance, analog-intensive mixed-signal solutions. The companys portfolio includes wireless microcontrollers, sensors, and IoT-enabled devices, catering to a broad spectrum of applications across industrial IoT, smart home, healthcare, and commercial markets. Its products are integral to applications such as industrial automation, smart metering, renewable energy, asset tracking, and medical instrumentation, as well as smart home systems, including cameras, locks, lighting, and security panels. The companys solutions also extend to connected health applications, such as diabetes management and patient monitoring.

Silicon Laboratories operates globally, with a strong presence in key markets like the United States, China, and Taiwan. Its products are distributed through a combination of direct sales channels and an extensive network of independent sales representatives and distributors. Founded in 1996 and headquartered in Austin, Texas, the company has established itself as a trusted provider of innovative semiconductor solutions for the IoT era. Web URL: https://www.silabs.com

3-Month Forecast: Based on , SLABs stock is currently trading below its 50-day SMA (120.21) and 200-day SMA (118.23), indicating potential downward pressure. The 20-day SMA (97.67) suggests near-term resistance at this level. With an ATR of 6.53, volatility is moderate, and traders may set stop-loss levels accordingly. From a perspective, the companys high P/S ratio (5.34) reflects premium pricing, while the negative RoE (-17.69) raises concerns about profitability. The forward P/E (322.58) indicates high market expectations, but this could pose risks if growth falters. Over the next three months, expect SLAB to remain range-bound between 90 and 110, with potential upside if the company demonstrates revenue growth or improved margins.

Additional Sources for SLAB Stock

SLAB Stock Overview

Market Cap in USD 3,373m
Sector Technology
Industry Semiconductors
GiC Sub-Industry Semiconductors
IPO / Inception 2000-03-23

SLAB Stock Ratings

Growth Rating 2.49
Fundamental -55.0
Dividend Rating 0.0
Rel. Strength -15.5
Analysts 3.55/5
Fair Price Momentum 86.82 USD
Fair Price DCF -

SLAB Dividends

No Dividends Paid

SLAB Growth Ratios

Growth Correlation 3m -88.8%
Growth Correlation 12m 8.1%
Growth Correlation 5y -10.3%
CAGR 5y 2.51%
CAGR/Max DD 5y 0.04
Sharpe Ratio 12m -0.47
Alpha -32.89
Beta 1.622
Volatility 73.86%
Current Volume 455.6k
Average Volume 20d 451.7k
What is the price of SLAB stocks?
As of May 01, 2025, the stock is trading at USD 101.76 with a total of 455,582 shares traded.
Over the past week, the price has changed by +5.86%, over one month by -9.60%, over three months by -24.95% and over the past year by -16.24%.
Is Silicon Laboratories a good stock to buy?
No, based on ValueRay Fundamental Analyses, Silicon Laboratories (NASDAQ:SLAB) is currently (May 2025) a stock to sell. It has a ValueRay Fundamental Rating of -54.95 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SLAB as of May 2025 is 86.82. This means that SLAB is currently overvalued and has a potential downside of -14.68%.
Is SLAB a buy, sell or hold?
Silicon Laboratories has received a consensus analysts rating of 3.55. Therefor, it is recommend to hold SLAB.
  • Strong Buy: 2
  • Buy: 2
  • Hold: 7
  • Sell: 0
  • Strong Sell: 0
What are the forecast for SLAB stock price target?
According to ValueRays Forecast Model, SLAB Silicon Laboratories will be worth about 101.3 in May 2026. The stock is currently trading at 101.76. This means that the stock has a potential downside of -0.47%.
Issuer Forecast Upside
Wallstreet Target Price 134.3 32%
Analysts Target Price 113.6 11.7%
ValueRay Target Price 101.3 -0.5%